MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
מצבים רפואיים
Recurrent Melanoma (Skin) · Metastatic Melanoma · Melanoma Stage IV · Melanoma Stage III
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of California Irvine, Orange, California, United States
Contact: Principal Investigator (Shyam Srinivas, MD)Mayo Clinic, Jacksonville, Florida, United States
Contact: Principal Investigator (Ruqin Chen, MD, MB)University of Miami, Miami, Florida, United States
Contact: Principal Investigator (Jose Lutzky, M.D.)Sarasota Memorial Hospital, Sarasota, Florida, United States
Contact: Principal Investigator (Kunal Saigal, MD)University of Iowa, Iowa City, Iowa, United States
Contact: Principal Investigator (Yusuf Menda, MD)Yousef Zakharia, MD (Sub-investigator)University of Kentucky, Lexington, Kentucky, United States
Contact: Principal Investigator (Ruta Arays, MD)Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Principal Investigator (Matthew S Block, MD, PhD)Geoffrey B Johnson, MD, PhD (Sub-investigator)Saint Louis University Hospital, St Louis, Missouri, United States
Contact: Principal Investigator (Medhat Osman, MD)Washington University of St. Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Richard Wahl, MD)Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Principal Investigator (Samuel Mehr, MD)Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Anthony Olszanski, MD)UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Ravi Patel, MD)University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States